These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30073673)

  • 1. In vitro assays and techniques utilized in anticancer drug discovery.
    Ediriweera MK; Tennekoon KH; Samarakoon SR
    J Appl Toxicol; 2019 Jan; 39(1):38-71. PubMed ID: 30073673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
    LaBarbera DV; Reid BG; Yoo BH
    Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking
    Jo Y; Choi N; Kim K; Koo HJ; Choi J; Kim HN
    Theranostics; 2018; 8(19):5259-5275. PubMed ID: 30555545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 3-D cell culture system for in vitro evaluation of anticancer drugs under anchorage-independent conditions.
    Aihara A; Abe N; Saruhashi K; Kanaki T; Nishino T
    Cancer Sci; 2016 Dec; 107(12):1858-1866. PubMed ID: 27699918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy.
    Kaemmerer E; Loessner D; Avery VM
    Drug Discov Today; 2021 Mar; 26(3):663-676. PubMed ID: 33278601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
    Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
    Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiologically relevant in vitro tumor models for drug screening.
    Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
    Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target Gene Discovery for Novel Therapeutic Agents in Cancer Treatment.
    Tiwari S; Ammerpohl O; Kalthoff H
    Methods Mol Biol; 2016; 1381():181-200. PubMed ID: 26667461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
    Meier-Hubberten JC; Sanderson MP
    Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current mathematical models for cancer drug discovery.
    Carrara L; Lavezzi SM; Borella E; De Nicolao G; Magni P; Poggesi I
    Expert Opin Drug Discov; 2017 Aug; 12(8):785-799. PubMed ID: 28595492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving anticancer drug development begins with cell culture: misinformation perpetrated by the misuse of cytotoxicity assays.
    Eastman A
    Oncotarget; 2017 Jan; 8(5):8854-8866. PubMed ID: 27750219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes.
    Jang JW; Song Y; Kim KM; Kim JS; Choi EK; Kim J; Seo H
    BMC Cancer; 2016 Oct; 16(1):810. PubMed ID: 27756242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer drug discovery using multicellular tumor spheroid models.
    Zanoni M; Pignatta S; Arienti C; Bonafè M; Tesei A
    Expert Opin Drug Discov; 2019 Mar; 14(3):289-301. PubMed ID: 30689452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group.
    Perego P; Hempel G; Linder S; Bradshaw TD; Larsen AK; Peters GJ; Phillips RM;
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):427-441. PubMed ID: 29285635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development.
    Hameed R; Khan A; Khan S; Perveen S
    Anticancer Agents Med Chem; 2019; 19(5):592-598. PubMed ID: 30306880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer drug discovery: recent innovative approaches to tumor modeling.
    Lovitt CJ; Shelper TB; Avery VM
    Expert Opin Drug Discov; 2016 Sep; 11(9):885-94. PubMed ID: 27454169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
    Pathania D; Millard M; Neamati N
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.